Sickle Cell Knowledge and Information Network (SCKIN) provides free, AI‑enabled chatbots—SickleCellPedia (English) and DrepanoPedia (French)—that deliver vetted medical information about sickle cell disease.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with sickle cell disease, especially those in the Global South, often lack reliable, easily accessible information about their condition, contributing to gaps in knowledge and reduced life expectancy.
Solution
SCKIN offers free, AI‑enabled chatbots—SickleCellPedia (English) and DrepanoPedia (French)—that provide accurate answers to user questions about sickle cell disease. The chatbots are accessible via a web widget on the SCKIN site and through WhatsApp, enabling users to obtain information on symptoms, treatment options, and disease management without needing medical expertise. By leveraging large language models fine‑tuned on vetted medical content, the bots deliver consistent, evidence‑based responses in real time. The service is offered at no cost, aiming to democratize health knowledge and support patients, families, and caregivers worldwide.
Target Audience
Primary users are individuals living with sickle cell disease, their families, and caregivers in regions with limited healthcare resources, particularly in the Global South.
Features
- AI‑driven conversational interface delivering vetted medical information on sickle cell disease
- Multilingual support (English and French) to reach diverse patient populations
- Accessible through a web chat widget and WhatsApp for low‑bandwidth environments
- Continuous updates to the knowledge base to reflect current clinical guidelines
- No registration or payment required, ensuring barrier‑free access